1. Home
  2. VCIG vs TXMD Comparison

VCIG vs TXMD Comparison

Compare VCIG & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VCIG
  • TXMD
  • Stock Information
  • Founded
  • VCIG 2013
  • TXMD 2008
  • Country
  • VCIG Malaysia
  • TXMD United States
  • Employees
  • VCIG N/A
  • TXMD N/A
  • Industry
  • VCIG Diversified Commercial Services
  • TXMD Biotechnology: Pharmaceutical Preparations
  • Sector
  • VCIG Consumer Discretionary
  • TXMD Health Care
  • Exchange
  • VCIG Nasdaq
  • TXMD Nasdaq
  • Market Cap
  • VCIG 15.4M
  • TXMD 17.9M
  • IPO Year
  • VCIG 2023
  • TXMD N/A
  • Fundamental
  • Price
  • VCIG $1.62
  • TXMD $1.41
  • Analyst Decision
  • VCIG
  • TXMD
  • Analyst Count
  • VCIG 0
  • TXMD 0
  • Target Price
  • VCIG N/A
  • TXMD N/A
  • AVG Volume (30 Days)
  • VCIG 705.6K
  • TXMD 17.4K
  • Earning Date
  • VCIG 11-26-2024
  • TXMD 11-12-2024
  • Dividend Yield
  • VCIG 30.25%
  • TXMD N/A
  • EPS Growth
  • VCIG N/A
  • TXMD N/A
  • EPS
  • VCIG 7.82
  • TXMD N/A
  • Revenue
  • VCIG $23,548,256.00
  • TXMD $1,596,000.00
  • Revenue This Year
  • VCIG N/A
  • TXMD $605.07
  • Revenue Next Year
  • VCIG N/A
  • TXMD $1.11
  • P/E Ratio
  • VCIG $0.21
  • TXMD N/A
  • Revenue Growth
  • VCIG 89.38
  • TXMD N/A
  • 52 Week Low
  • VCIG $1.38
  • TXMD $1.38
  • 52 Week High
  • VCIG $179.83
  • TXMD $3.07
  • Technical
  • Relative Strength Index (RSI)
  • VCIG 26.44
  • TXMD 19.09
  • Support Level
  • VCIG $1.38
  • TXMD $1.47
  • Resistance Level
  • VCIG $1.80
  • TXMD $1.58
  • Average True Range (ATR)
  • VCIG 0.59
  • TXMD 0.06
  • MACD
  • VCIG -0.03
  • TXMD -0.01
  • Stochastic Oscillator
  • VCIG 4.50
  • TXMD 13.23

About VCIG VCI Global Limited

VCI Global Ltd is a holding company. The principal activities of the Company and its subsidiaries are the provision of business Strategy consultancy and technology development solution consultancy. The firm organized its consulting services into three main segments: Business Strategy Consultancy; Technology Consultancy; and Others. It derives the majority of its revenue from the Business Strategy Consultancy segment which focuses on listing solutions, investor relations, and boardroom strategies consultancy. It has established a diverse local and international clientele, providing them with its services in both local and cross-border listings. Its role begins with pre-listing diagnosis and planning to the finalization of the entire listing process.

About TXMD TherapeuticsMD Inc.

TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.

Share on Social Networks: